RepliCel Life Sciences Inc (OTCQB:REPCF)

0.2784
Delayed Data
As of Jun 22
 +0.0213 / +8.29%
Today’s Change
0.25
Today|||52-Week Range
0.55
-10.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization6.9K5.5K4.4K3.2K
 
 
 
 
 
 
Operating ExpensesGross Income-6.9K-5.5K-4.4K-3.2K
 
 
 
 
 
General Expenses4.7M3.9M3.2M4.6M
 
 
 
 
 
Research And Development1.8M1.8M841.6K2.0M
 
 
 
 
 
Total Operating Expenses4.7M3.9M3.2M4.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-3.9M-3.2M-4.6M
 
 
 
 
 
Extraordinary Credit0.002.8K0.000.00
 
 
Extraordinary Charge-7.0K0.000.000.00
 
 
Other Expenses3.2K-12.1K12.3K-22.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-3.9M-3.2M-4.6M
 
 
 
 
 
Net Income-4.7M-3.9M-3.2M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.1M5.7M8.0M18.7M
 
 
 
 
 
Shares To Calculate EPS Diluted5.1M5.7M8.0M18.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$0.70-$0.41-$0.25
 
 
 
 
 
EPS Diluted-$0.91-$0.70-$0.41-$0.25